{
    "2019-01-07": [
        [
            {
                "time": "2018-03-15",
                "original_text": "AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "outpaces",
                        "stock market gains"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-20",
                "original_text": "Peninsula Alzheimer's fighter hunts $150 million IPO",
                "features": {
                    "keywords": [
                        "Peninsula",
                        "Alzheimer's",
                        "IPO"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-05-10",
                "original_text": "Neurocrine Gives Ingrezza Sales View, Updates on Pipeline",
                "features": {
                    "keywords": [
                        "Neurocrine",
                        "Ingrezza",
                        "sales view",
                        "pipeline updates"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-05",
                "original_text": "Neurocrine Biosciences Is a Pharma Stock to Watch",
                "features": {
                    "keywords": [
                        "Neurocrine Biosciences",
                        "pharma stock"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-07-12",
                "original_text": "Notable ETF Inflow Detected - SDY, T, O, ABBV",
                "features": {
                    "keywords": [
                        "ETF inflow",
                        "SDY",
                        "T",
                        "O",
                        "ABBV"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "dividend stocks"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-25",
                "original_text": "As Patent Expirations Loom, the Clock Is Ticking on AbbVie Stock",
                "features": {
                    "keywords": [
                        "patent expirations",
                        "AbbVie"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-09-18",
                "original_text": "Gilead (GILD) Collaborates With Yuhan for NASH Candidates",
                "features": {
                    "keywords": [
                        "Gilead",
                        "collaborates",
                        "Yuhan",
                        "NASH candidates"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-03",
                "original_text": "Jim Cramer Gives His Opinion On Ciena, Momo, Qualcomm And More",
                "features": {
                    "keywords": [
                        "Jim Cramer",
                        "opinion",
                        "Ciena",
                        "Momo",
                        "Qualcomm"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-11-22",
                "original_text": "Today's Research Reports on Trending Tickers: AbbVie and Allergan",
                "features": {
                    "keywords": [
                        "research reports",
                        "trending tickers",
                        "AbbVie",
                        "Allergan"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-12-15",
                "original_text": "The Zacks Analyst Blog Highlights: Bristol-Myers, Celgene, Merck, Pfizer and AbbVie",
                "features": {
                    "keywords": [
                        "Zacks Analyst Blog",
                        "Bristol-Myers",
                        "Celgene",
                        "Merck",
                        "Pfizer",
                        "AbbVie"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-01-10",
                "original_text": "3 Bargain Stocks You Can Buy Right Now",
                "features": {
                    "keywords": [
                        "bargain stocks",
                        "buy right now"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}